Int. Society Clinical Densitometry (ISCD)
He has 38 years of broad experience in:
He has delivered hundreds of CME and non-CME lectures nationally and internationally for industry, academia, scientific, and philanthropic organizations.
In addition to be a retired Air force Squadron Leader, he has experience with patent litigation as an expert scientific witness, reviewer for NIH, NASA, DEA, and VA, and experience in dealing with the FDA, media, and legislature.
He has been a chairperson or a board of director of several non-profit foundations and scientific organizations, and has conducted a number of philanthropic work over the past 40 years.
He has successfully completed the National Faculty Education Initiative.
Founding (and current) President: International foundation for Chronic Disabilities (IFCD)
Past President: International Foundation of Revitalization, Education, Empowerment & Development
Founding (and current) President: Wimalawansa Foundation
Founding (& current) President: Education Trust Fund for Disadvantaged Children (WETF)
Founding (and current) President: Foundation for Preventive Health, Environmental Protection, and Research
Established a self-funded university-approved regional center of excellence with a major grant from the federal government.
The center was fully funded and managed with grants and income it generated.
He and two colleagues founded this Biotech Company using a product for which he holds the patents. Company is engaged on IND-based phase II and III clinical trials using two of its novel products.
Dr Wimalawansa is the founder and the chair of the board of CG-Therapeutics.
Director of the Metabolic Bone Center, and the director, biochemical endocrinology unit
Annually, averaged six peer-reviewed scientific papers in high-impact journals.
Initiated multiple collaborative research programs leading to state and federal grant funding.
Both the self-sustaining/self-funded research unit and the Osteoporosis Center were built from the ground up and funded by grants from the Texas Higher Education Coordinating Board and National Institutes of Health.
Managed this large diabetes referral center with more than 35,000 annual clinic visits. Significantly enhanced efficiency of the center by streamlining its operation and referral base, and cutting the wait list time from 9 months to 4 weeks.
Consultant Physician & Endocrinologist, Hammersmith Hospital, Du Cane Road, London
Director, Chemical Pathology & Endocrinology, Royal Postgraduate Medical
He initiated this research unit funded by the British Heart Foundation. On average, seven peer- reviewed scientific papers published each year in high-impact journals.
Successfully managed the department with approximately 50 employees and a budget of $24 million
Medicolegal work [osteoporosis, metabolic bone disease, and general endocrinology]:
• Amgen Pharmaceuticals
• Eli Lilly Pharmaceuticals
• Novartis Pharmaceuticals
• Procter and Gamble (NPF)
• Aventis Pharmaceuticals (NPF)
• Wyeth-Ayerst Pharmaceuticals
• AstraZeneca Pharmaceuticals
• Bayer Pharmaceuticals
• Apotex, Inc.
• Teva Pharmaceuticals
Nutrition, Vitamin D, Obesity, & Type 2 Diabetes:
Osteoporosis and BMD testing:
General endocrinology topics:
Leadership Training topics:
Prevention of premature deaths from chronic kidney failure (CKDuo / CKDmfo):
Wimalawansa Education Trust Fund (WETF):
International Foundation for Chronic Disabilities (IFCD):
Global philanthropic work:
Medical & Research Interests:
First prize, Annual open, Business Plan Competition, 2005, Rutgers Business University
Leadership & Managmeent
Medicine, Surgery, Obstetrics/Gyn, and Pediatrics
Inactive: Pennsylvania; Texas, and Tennessee
Scientific Publications and related work:
Have published 165 peer-reviewed academic articles, 45 reviews & proceedings, 15 book chapters, and 5 medical books, 50 medicine grand-rounds, over 285 scientific presentations; multiple non-medical lectures; and holds 5 medical U.S. and international patents.
A regular reviewer for several national and international scientific journals and has served on editorial boards and in several national and international scientific review committees (NIH, VA, DEA, and NASA).
Has delivered over 200 national and international invited lectures
Current academic and charitable work:
(A) teaching in Medical Education (CME) programs, and writing a series of medical and philosophy books,
(B) teach endocrinology & nutrition CME programs, symposia and courses globally, and engaged in web-based teaching,
(C) managing an education foundation and philanthropic work including, establishing novel, cost-effective water purification methods applicable to developing countries,
(D) broader programs to alleviate chronic kidney disease of unknown etiology from affected countries,
(E) programs design to alleviate malnutrition in pregnant mothers in a infants,
(F) development of unique, international educational nature center in Sri Lanka (PHEPRO Foundation), and
(G) job creation, poverty alleviation, provision of shelter, safe sanitation and clean water, economic development, and women’s empowerment in deprived regions (https://wimalawansa.org).